ÂÜÀòÂÒÂ×

Guillaume Mabilleau is currently the Site Manager for the Inserm UMR-S 1229 RMeS REGOS team at Université d'Angers, overseeing a major research unit focused on skeletal sciences that resulted from a merger in January 2022. In addition to this role, Guillaume Mabilleau serves as a Clinical Lecturer in Histology, Embryology, and Cytology, teaching medical students and contributing to the Bone Pathology Unit at the university hospital. As Director of the GEROM UPRES EA 4658 lab, Guillaume leads the "Gut and Bone" research axis. Furthermore, Guillaume Mabilleau holds the position of Chief Scientific Officer and Head of the Bone Pathology Unit at CHU d'Angers, where the focus is on histological investigations related to metabolic bone disorders. Prior experience includes roles at the University of Oxford and advanced academic qualifications in the field of bone biology and biomaterials.